Trial Profile
A Study Evaluating Association Of Pneumonitis With Efficacy Outcomes In Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Everolimus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 01 Aug 2017 Results published in the European Journal of Cancer
- 23 Dec 2016 New trial record